group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00032,0.2114816744493214,FUN_000238-T1,Peve_00033352,Pocillopora_meandrina_HIv1___RNAseq.g28954.t1,three_way,62.998666666666665,FUN_000238-T1,Q5ZI58,,,,,35.3,552.0,1e-61,239.6,sp|Q5ZI58|ATOSA_CHICK Atos homolog protein A OS=Gallus gallus OX=9031 GN=ATOSA PE=2 SV=2,,,,,,
OG_00296,0.2271105958576571,FUN_001087-T1,Peve_00003172,Pocillopora_meandrina_HIv1___RNAseq.g29386.t1,three_way,70.96266666666666,,,,,,,,,,,,,,,,,
OG_00356,0.6239860860586081,FUN_001188-T1,Peve_00009673,Pocillopora_meandrina_HIv1___TS.g6724.t2,three_way,43.03966666666667,,,,,,,,,,,,,,,,,
OG_00506,0.0976160335803238,FUN_001482-T1,Peve_00029349,Pocillopora_meandrina_HIv1___TS.g4428.t1,three_way,67.89966666666666,FUN_001482-T1,Q6GLB9,,,,,75.4,69.0,1.4e-20,101.3,sp|Q6GLB9|EMX1_XENTR Homeobox protein EMX1 OS=Xenopus tropicalis OX=8364 GN=emx1 PE=2 SV=1,,,,,,
OG_00568,0.2201771037385603,FUN_001624-T2,Peve_00042511,Pocillopora_meandrina_HIv1___TS.g4673.t1,three_way,69.09666666666666,FUN_001624-T2,Q8NHX9,TPC2_HUMAN,,Two pore channel protein 2 (Two pore calcium channel protein 2),Homo sapiens (Human),44.0,728.0,2e-149,531.2,sp|Q8NHX9|TPC2_HUMAN Two pore channel protein 2 OS=Homo sapiens OX=9606 GN=TPCN2 PE=1 SV=2,GO:0005245; GO:0005262; GO:0005764; GO:0005765; GO:0005829; GO:0006874; GO:0006939; GO:0007040; GO:0010008; GO:0010506; GO:0015280; GO:0017157; GO:0019065; GO:0019722; GO:0019901; GO:0031902; GO:0033162; GO:0033280; GO:0034220; GO:0034702; GO:0035725; GO:0036020; GO:0042802; GO:0048086; GO:0051209; GO:0051452; GO:0072345; GO:0075509; GO:0080025; GO:0090117; GO:0097682,calcium-mediated signaling [GO:0019722]; endocytosis involved in viral entry into host cell [GO:0075509]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; intracellular calcium ion homeostasis [GO:0006874]; intracellular pH reduction [GO:0051452]; lysosome organization [GO:0007040]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of developmental pigmentation [GO:0048086]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; release of sequestered calcium ion into cytosol [GO:0051209]; response to vitamin D [GO:0033280]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725],cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; monoatomic ion channel complex [GO:0034702],"calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]",GO:0003012; GO:0005215; GO:0005764; GO:0005773; GO:0005829; GO:0007040; GO:0008289; GO:0016192; GO:0043226; GO:0055085,muscle system process; transporter activity; lysosome; vacuole; cytosol; lysosome organization; lipid binding; vesicle-mediated transport; organelle; transmembrane transport
OG_00656,0.2934442914726087,FUN_001943-T1,Peve_00041248,Pocillopora_meandrina_HIv1___RNAseq.g2485.t1,three_way,67.74316666666667,FUN_001943-T1,Q3TC46,PATL1_MOUSE,,Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b),Mus musculus (Mouse),27.4,602.0,3.4e-40,168.3,sp|Q3TC46|PATL1_MOUSE Protein PAT1 homolog 1 OS=Mus musculus OX=10090 GN=Patl1 PE=1 SV=2,GO:0000290; GO:0000932; GO:0002151; GO:0003723; GO:0005737; GO:0005829; GO:0008266; GO:0016605; GO:0016607; GO:0017148; GO:0030014; GO:0030371; GO:0033962; GO:0034046,deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962],CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605],G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371],GO:0003723; GO:0005829; GO:0016071; GO:0043226; GO:0045182,RNA binding; cytosol; mRNA metabolic process; organelle; translation regulator activity
OG_01174,0.28933007938092,FUN_004803-T2,Peve_00023849,Pocillopora_meandrina_HIv1___RNAseq.g8569.t1,three_way,51.61816666666667,FUN_004803-T2,A7E2V4,ZSWM8_HUMAN,,Zinc finger SWIM domain-containing protein 8,Homo sapiens (Human),29.1,453.0,2.6e-39,166.4,sp|A7E2V4|ZSWM8_HUMAN Zinc finger SWIM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=ZSWIM8 PE=1 SV=1,GO:0005829; GO:0006515; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:0140958; GO:1990756; GO:2000627,positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829],ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270],GO:0005829; GO:0030163; GO:0060090,cytosol; protein catabolic process; molecular adaptor activity
OG_01191,0.2405045836175942,FUN_004845-T1,Peve_00019432,Pocillopora_meandrina_HIv1___RNAseq.g8622.t1,three_way,81.704,FUN_004845-T1,Q9PTS8,ACHA9_CHICK,,Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9),Gallus gallus (Chicken),39.9,476.0,7.3000000000000015e-87,322.8,sp|Q9PTS8|ACHA9_CHICK Neuronal acetylcholine receptor subunit alpha-9 OS=Gallus gallus OX=9031 GN=CHRNA9 PE=1 SV=1,GO:0005231; GO:0005262; GO:0005886; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:1902495; GO:1904315,chemical synaptic transmission [GO:0007268]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391],neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495],acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_01312,0.5171068882836549,FUN_005175-T1,Peve_00011874,Pocillopora_meandrina_HIv1___RNAseq.g7581.t1,three_way,61.32216666666667,FUN_005175-T1,Q9VW71,,,,,22.0,2889.0,4.9e-74,283.1,sp|Q9VW71|FAT2_DROME Fat-like cadherin-related tumor suppressor homolog OS=Drosophila melanogaster OX=7227 GN=kug PE=2 SV=3,,,,,,
OG_01314,0.5001299706437504,FUN_005177-T1,Peve_00022720,Pocillopora_meandrina_HIv1___RNAseq.g7584.t1,three_way,78.689,FUN_005177-T1,Q7Z401,MYCPP_HUMAN,,C-myc promoter-binding protein (DENN domain-containing protein 4A),Homo sapiens (Human),34.8,1885.0,8.6e-282,971.8,sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2,GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483,regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_01601,0.1123094299008671,FUN_006644-T1,Peve_00029043,Pocillopora_meandrina_HIv1___RNAseq.g19946.t1,three_way,68.10000000000001,FUN_006644-T1,Q5QNP2,TA13C_DANRE,,Trace amine-associated receptor 13c,Danio rerio (Zebrafish) (Brachydanio rerio),27.8,277.0,2.4e-07,58.2,sp|Q5QNP2|TA13C_DANRE Trace amine-associated receptor 13c OS=Danio rerio OX=7955 GN=taar13c PE=1 SV=1,GO:0001594; GO:0004984; GO:0005886; GO:0007186; GO:0007606; GO:0008227; GO:0009995; GO:0016020; GO:0019808; GO:0019810; GO:0050911; GO:1990834,detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; response to odorant [GO:1990834]; sensory perception of chemical stimulus [GO:0007606]; soluble molecule recognition [GO:0009995],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled amine receptor activity [GO:0008227]; olfactory receptor activity [GO:0004984]; polyamine binding [GO:0019808]; putrescine binding [GO:0019810]; trace-amine receptor activity [GO:0001594],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_01649,0.348880087376436,FUN_006803-T2,Peve_00029309,Pocillopora_meandrina_HIv1___RNAseq.g20491.t1,three_way,82.40566666666668,FUN_006803-T2,A1L1C7,PAN3_XENTR,,PAN2-PAN3 deadenylation complex subunit pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),51.1,626.0,6.2e-166,585.9,sp|A1L1C7|PAN3_XENTR PAN2-PAN3 deadenylation complex subunit pan3 OS=Xenopus tropicalis OX=8364 GN=pan3 PE=2 SV=1,GO:0000289; GO:0000932; GO:0003723; GO:0004672; GO:0005524; GO:0006397; GO:0008270; GO:0010606; GO:0031251,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],P-body [GO:0000932]; PAN complex [GO:0031251],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01740,0.611328259303176,FUN_007062-T1,Peve_00025326,Pocillopora_meandrina_HIv1___RNAseq.g20109.t1,three_way,70.79983333333334,FUN_007062-T1,Q8IX03,KIBRA_HUMAN,,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),Homo sapiens (Human),29.0,1136.0,8.3e-51,204.1,sp|Q8IX03|KIBRA_HUMAN Protein KIBRA OS=Homo sapiens OX=9606 GN=WWC1 PE=1 SV=1,GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0043410; GO:0046621; GO:0048471; GO:0060090,cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0007163; GO:0043226; GO:0048870; GO:0060090; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_01785,0.198476967382004,FUN_007161-T1,Peve_00042489,Pocillopora_meandrina_HIv1___RNAseq.g19738.t2,three_way,80.99133333333333,FUN_007161-T1,P46019,KPB2_HUMAN,,"Phosphorylase b kinase regulatory subunit alpha, liver isoform (Phosphorylase kinase alpha L subunit)",Homo sapiens (Human),48.8,1257.0,0.0,1095.9,"sp|P46019|KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha, liver isoform OS=Homo sapiens OX=9606 GN=PHKA2 PE=1 SV=1",GO:0004689; GO:0005516; GO:0005829; GO:0005886; GO:0005964; GO:0005975; GO:0005977; GO:0006091; GO:0036211,carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; protein modification process [GO:0036211],cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689],GO:0003824; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0016740; GO:0140096,"catalytic activity; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; catalytic activity, acting on a protein"
OG_02035,0.2699721459942478,FUN_008237-T1,Peve_00003879,Pocillopora_meandrina_HIv1___RNAseq.g17928.t1,three_way,82.36666666666666,FUN_008237-T1,Q29RK2,PYC_BOVIN,,"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)",Bos taurus (Bovine),65.5,1165.0,0.0,1567.0,"sp|Q29RK2|PYC_BOVIN Pyruvate carboxylase, mitochondrial OS=Bos taurus OX=9913 GN=PC PE=2 SV=2",GO:0004736; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0046872,gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; pyruvate metabolic process [GO:0006090],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736],GO:0003824; GO:0005739; GO:0005975; GO:0006629; GO:0016874; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lipid metabolic process; ligase activity; organelle
OG_02100,0.3047311413121619,FUN_008373-T1,Peve_00007049,Pocillopora_meandrina_HIv1___RNAseq.g5698.t1,three_way,56.7935,FUN_008373-T1,Q9NR16,,,,,29.6,1021.0,1.2999999999999999e-107,393.3,sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2,,,,,,
OG_02221,0.4487257988127383,FUN_008616-T2,Peve_00015392,Pocillopora_meandrina_HIv1___RNAseq.g12745.t1,three_way,74.7925,FUN_008616-T2,E7FDW2,,,,,28.2,602.0,3.1000000000000003e-57,225.3,sp|E7FDW2|PZR3B_DANRE E3 ubiquitin-protein ligase PDZRN3-B OS=Danio rerio OX=7955 GN=pdzrn3b PE=1 SV=1,,,,,,
OG_02767,0.433023850399994,FUN_011706-T2,Peve_00025155,Pocillopora_meandrina_HIv1___RNAseq.g23820.t1,three_way,66.33966666666666,FUN_011706-T2,O95835,LATS1_HUMAN,,Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts),Homo sapiens (Human),38.3,1163.0,3.9e-172,607.1,sp|O95835|LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens OX=9606 GN=LATS1 PE=1 SV=1,GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033146; GO:0035329; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051301; GO:0060644; GO:0090090; GO:0098794; GO:0098978; GO:0099151; GO:0106310; GO:1900181; GO:1900227; GO:2000058,cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0007059; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; chromosome segregation; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_03207,0.5269959467157304,FUN_012699-T1,Peve_00016830,Pocillopora_meandrina_HIv1___RNAseq.g22854.t1,three_way,70.60966666666667,FUN_012699-T1,O94923,GLCE_HUMAN,,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),Homo sapiens (Human),44.1,612.0,9.099999999999999e-137,488.8,sp|O94923|GLCE_HUMAN D-glucuronyl C5-epimerase OS=Homo sapiens OX=9606 GN=GLCE PE=1 SV=3,GO:0000139; GO:0005509; GO:0005794; GO:0008284; GO:0015012; GO:0016857; GO:0030210; GO:0031345; GO:0042803; GO:0047464; GO:0060391,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; negative regulation of cell projection organization [GO:0031345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of SMAD protein signal transduction [GO:0060391],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]",GO:0003824; GO:0005794; GO:0009101; GO:0016853; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; isomerase activity; organelle; carbohydrate derivative metabolic process
OG_03245,0.1957883179885364,FUN_012880-T1,Peve_00029266,Pocillopora_meandrina_HIv1___RNAseq.g12951.t1,three_way,80.52533333333334,,,,,,,,,,,,,,,,,
OG_03247,0.3915849554056656,FUN_012926-T1,Peve_00000427,Pocillopora_meandrina_HIv1___TS.g1951.t2a,three_way,82.53266666666667,FUN_012926-T1,D3ZG27,UBIA1_RAT,,UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (EC 2.5.1.39),Rattus norvegicus (Rat),58.4,293.0,3.7e-86,319.7,sp|D3ZG27|UBIA1_RAT UbiA prenyltransferase domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Ubiad1 PE=3 SV=1,GO:0000139; GO:0001885; GO:0004659; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006744; GO:0009233; GO:0009234; GO:0016020; GO:0016209; GO:0031966; GO:0042371; GO:0042374; GO:0072359,circulatory system development [GO:0072359]; endothelial cell development [GO:0001885]; menaquinone biosynthetic process [GO:0009234]; menaquinone metabolic process [GO:0009233]; phylloquinone metabolic process [GO:0042374]; ubiquinone biosynthetic process [GO:0006744]; vitamin K biosynthetic process [GO:0042371],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634],antioxidant activity [GO:0016209]; prenyltransferase activity [GO:0004659],GO:0003824; GO:0005634; GO:0005783; GO:0006766; GO:0016209; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; endoplasmic reticulum; vitamin metabolic process; antioxidant activity; transferase activity; organelle; anatomical structure development
OG_03618,0.3829595811254139,FUN_014803-T1,Peve_00010343,Pocillopora_meandrina_HIv1___RNAseq.g22413.t1,three_way,74.0495,FUN_014803-T1,Q3UQ28,PXDN_MOUSE,,Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Mus musculus (Mouse),52.2,1478.0,0.0,1216.8,sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005198; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003,catalytic activity; structural molecule activity; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly
OG_03621,0.2793200271621825,FUN_014808-T1,Peve_00023295,Pocillopora_meandrina_HIv1___RNAseq.g22408.t1,three_way,88.98733333333334,FUN_014808-T1,Q86YT6,MIB1_HUMAN,,E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2),Homo sapiens (Human),73.7,1031.0,0.0,1109.7,sp|Q86YT6|MIB1_HUMAN E3 ubiquitin-protein ligase MIB1 OS=Homo sapiens OX=9606 GN=MIB1 PE=1 SV=1,GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0021953; GO:0031410; GO:0034451; GO:0045665; GO:0045807; GO:0061630; GO:0098978,blood vessel development [GO:0001568]; central nervous system neuron differentiation [GO:0021953]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03825,0.3255901098801103,FUN_015245-T1,Peve_00003467,Pocillopora_meandrina_HIv1___RNAseq.g22163.t1,three_way,72.38283333333334,FUN_015245-T1,Q6VAB6,KSR2_HUMAN,,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),Homo sapiens (Human),33.3,953.0,6.5e-104,380.2,sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2,GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162,calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_03835,0.2963254599301623,FUN_015292-T1,Peve_00025007,Pocillopora_meandrina_HIv1___RNAseq.g22112.t1,three_way,67.77799999999999,FUN_015292-T1,P22439,,,,,48.2,448.0,2.2000000000000002e-101,370.9,sp|P22439|ODPX_BOVIN Pyruvate dehydrogenase protein X component OS=Bos taurus OX=9913 GN=PDHX PE=1 SV=3,,,,,,
OG_03979,0.2552110501035972,FUN_016137-T1,Peve_00022581,Pocillopora_meandrina_HIv1___RNAseq.g22030.t1,three_way,83.41883333333334,FUN_016137-T1,Q810B6,ANFY1_MOUSE,,Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif),Mus musculus (Mouse),49.1,1329.0,3.3e-253,876.7,sp|Q810B6|ANFY1_MOUSE Rabankyrin-5 OS=Mus musculus OX=10090 GN=Ankfy1 PE=1 SV=2,GO:0005769; GO:0005829; GO:0006897; GO:0008270; GO:0010008; GO:0030904; GO:0031267; GO:0034058; GO:0042147; GO:0044354; GO:0048549; GO:0090160; GO:1901981,"endocytosis [GO:0006897]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; macropinosome [GO:0044354]; retromer complex [GO:0030904],phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0005768; GO:0005829; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; cytosol; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_04004,0.3586737514271235,FUN_016302-T1,Peve_00032295,Pocillopora_meandrina_HIv1___RNAseq.g10043.t1,three_way,79.83366666666666,FUN_016302-T1,Q9UIU6,,,,,70.9,179.0,4.1e-71,269.6,sp|Q9UIU6|SIX4_HUMAN Homeobox protein SIX4 OS=Homo sapiens OX=9606 GN=SIX4 PE=1 SV=2,,,,,,
OG_04299,0.4261651383570682,FUN_017868-T1,Peve_00020409,Pocillopora_meandrina_HIv1___RNAseq.g9556.t1,three_way,92.76516666666666,FUN_017868-T1,Q6DKN2,,,,,73.3,86.0,6.7e-28,125.6,sp|Q6DKN2|OTX2B_XENLA Homeobox protein OTX2-B OS=Xenopus laevis OX=8355 GN=otx2-b PE=2 SV=1,,,,,,
OG_04326,0.328581601635058,FUN_017929-T1,Peve_00001599,Pocillopora_meandrina_HIv1___RNAseq.g283.t1,three_way,89.11483333333334,FUN_017929-T1,O75165,DJC13_HUMAN,,DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8),Homo sapiens (Human),66.3,1643.0,0.0,2240.3,sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5,GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641,endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667],,GO:0005829; GO:0005886; GO:0016192; GO:0030154; GO:0043226,cytosol; plasma membrane; vesicle-mediated transport; cell differentiation; organelle
OG_04376,0.4916395383086331,FUN_018042-T1,Peve_00021780,Pocillopora_meandrina_HIv1___RNAseq.g25354.t1,three_way,62.6125,FUN_018042-T1,P25931,,,,,24.0,263.0,3.1e-06,54.7,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_04438,0.2052996818423502,FUN_018824-T1,Peve_00035784,Pocillopora_meandrina_HIv1___RNAseq.g9870.t1,three_way,86.71033333333334,FUN_018824-T1,P11586,C1TC_HUMAN,,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]",Homo sapiens (Human),69.7,935.0,0.0,1325.1,"sp|P11586|C1TC_HUMAN C-1-tetrahydrofolate synthase, cytoplasmic OS=Homo sapiens OX=9606 GN=MTHFD1 PE=1 SV=4",GO:0001780; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0007507; GO:0009086; GO:0009152; GO:0009257; GO:0016020; GO:0019346; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062,10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleotide biosynthetic process [GO:0009152]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486],GO:0002376; GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006575; GO:0006790; GO:0016491; GO:0016787; GO:0016874; GO:0043226; GO:0048856; GO:0055086; GO:1901135,immune system process; catalytic activity; mitochondrion; cytosol; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; hydrolase activity; ligase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04556,0.1456147252370961,FUN_022187-T1,Peve_00038022,Pocillopora_meandrina_HIv1___RNAseq.g4792.t1,three_way,81.82866666666666,FUN_022187-T1,Q91YJ2,SNX4_MOUSE,,Sorting nexin-4,Mus musculus (Mouse),42.4,425.0,1.8e-91,337.8,sp|Q91YJ2|SNX4_MOUSE Sorting nexin-4 OS=Mus musculus OX=10090 GN=Snx4 PE=1 SV=1,GO:0005154; GO:0005158; GO:0005769; GO:0005868; GO:0005886; GO:0015031; GO:0031201; GO:0031901; GO:0032266; GO:0032456; GO:0035091; GO:0098830; GO:1903595; GO:1990459; GO:1990460; GO:2000786,endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031],cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; presynaptic endosome [GO:0098830]; SNARE complex [GO:0031201],epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; transferrin receptor binding [GO:1990459],GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_04568,0.5053572435606938,FUN_022212-T1,Peve_00008597,Pocillopora_meandrina_HIv1___RNAseq.g4763.t1,three_way,72.44316666666667,FUN_022212-T1,Q14554,PDIA5_HUMAN,,Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein),Homo sapiens (Human),38.8,405.0,1.2e-71,272.7,sp|Q14554|PDIA5_HUMAN Protein disulfide-isomerase A5 OS=Homo sapiens OX=9606 GN=PDIA5 PE=1 SV=1,GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0015035; GO:0016491; GO:0022900,electron transport chain [GO:0022900]; protein folding [GO:0006457],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],oxidoreductase activity [GO:0016491]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],GO:0003824; GO:0005783; GO:0006091; GO:0006457; GO:0016491; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; generation of precursor metabolites and energy; protein folding; oxidoreductase activity; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_04959,0.2672398697308044,FUN_023050-T1,Peve_00008516,Pocillopora_meandrina_HIv1___RNAseq.g3873.t1,three_way,85.382,FUN_023050-T1,Q7M760,ZRAN1_MOUSE,,Ubiquitin thioesterase Zranb1 (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1),Mus musculus (Mouse),46.4,724.0,1.2e-185,651.4,sp|Q7M760|ZRAN1_MOUSE Ubiquitin thioesterase Zranb1 OS=Mus musculus OX=10090 GN=Zranb1 PE=2 SV=1,GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0008270; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0035523; GO:0070530; GO:0070536; GO:0071947; GO:1990168,cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0007010; GO:0016787; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton organization; hydrolase activity; organelle; cell motility; catalytic activity, acting on a protein"
OG_05049,0.2724278096326058,FUN_023239-T1,Peve_00029850,Pocillopora_meandrina_HIv1___RNAseq.g17390.t1,three_way,93.638,FUN_023239-T1,Q6DCT2,,,,,58.7,688.0,2e-218,760.4,sp|Q6DCT2|ARMD3_XENLA Armadillo-like helical domain-containing protein 3 OS=Xenopus laevis OX=8355 GN=armh3 PE=2 SV=2,,,,,,
OG_05340,0.4293390230593041,FUN_024063-T1,Peve_00000155,Pocillopora_meandrina_HIv1___RNAseq.g19256.t1,three_way,75.40483333333333,FUN_024063-T1,Q9P241,AT10D_HUMAN,,Phospholipid-transporting ATPase VD (EC 7.6.2.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D),Homo sapiens (Human),43.6,1316.0,3.3999999999999998e-279,963.0,sp|Q9P241|AT10D_HUMAN Phospholipid-transporting ATPase VD OS=Homo sapiens OX=9606 GN=ATP10D PE=1 SV=3,GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0016020; GO:0016887; GO:0034220; GO:0045332; GO:0140326; GO:0140351; GO:1990531,monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005215; GO:0005654; GO:0005783; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleoplasm; endoplasmic reticulum; plasma membrane; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
OG_05623,0.2405615826610699,FUN_025317-T1,Peve_00027085,Pocillopora_meandrina_HIv1___RNAseq.g13426.t1,three_way,77.72999999999999,FUN_025317-T1,Q92685,ALG3_HUMAN,,"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)",Homo sapiens (Human),57.3,403.0,6.1e-119,429.1,"sp|Q92685|ALG3_HUMAN Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG3 PE=1 SV=1",GO:0000033; GO:0005783; GO:0005789; GO:0006486; GO:0006487; GO:0006488; GO:0052925; GO:0098553,dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553],"alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]",GO:0003824; GO:0005783; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_05662,0.1758532344951018,FUN_025431-T1,Peve_00034116,Pocillopora_meandrina_HIv1___RNAseq.g13326.t1,three_way,68.45533333333333,FUN_025431-T1,A0A0R4IB93,UBP48_DANRE,,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Ubiquitin specific peptidase 48),Danio rerio (Zebrafish) (Brachydanio rerio),41.9,1141.0,1.6999999999999994e-242,840.9,sp|A0A0R4IB93|UBP48_DANRE Ubiquitin carboxyl-terminal hydrolase 48 OS=Danio rerio OX=7955 GN=usp48 PE=3 SV=1,GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016579; GO:0031647; GO:1904888,cranial skeletal system development [GO:1904888]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05672,0.300328879962702,FUN_025466-T1,Peve_00043837,Pocillopora_meandrina_HIv1___RNAseq.g13240.t1,three_way,86.86633333333333,FUN_025466-T1,Q8VDJ3,,,,,52.2,1291.0,0.0,1320.8,sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1,,,,,,
OG_05692,0.2248442989888951,FUN_025543-T1,Peve_00002302,Pocillopora_meandrina_HIv1___RNAseq.g13797.t1,three_way,76.96466666666667,FUN_025543-T1,A2A825,CPLN2_MOUSE,,Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1),Mus musculus (Mouse),54.1,181.0,2.6999999999999997e-55,216.5,sp|A2A825|CPLN2_MOUSE Ciliogenesis and planar polarity effector 2 OS=Mus musculus OX=10090 GN=Cplane2 PE=1 SV=1,GO:0003274; GO:0003924; GO:0005525; GO:0005737; GO:0005814; GO:0006887; GO:0007224; GO:0008104; GO:0008589; GO:0015031; GO:0016485; GO:0017157; GO:0031338; GO:0035082; GO:0035869; GO:0036064; GO:0060173; GO:0060271; GO:0097546; GO:1904888,axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cranial skeletal system development [GO:1904888]; endocardial cushion fusion [GO:0003274]; exocytosis [GO:0006887]; limb development [GO:0060173]; protein localization [GO:0008104]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of smoothened signaling pathway [GO:0008589]; regulation of vesicle fusion [GO:0031338]; smoothened signaling pathway [GO:0007224],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005815; GO:0007010; GO:0007155; GO:0016192; GO:0016787; GO:0043226; GO:0044782; GO:0048856; GO:0051604,catalytic activity; GTPase activity; microtubule organizing center; cytoskeleton organization; cell adhesion; vesicle-mediated transport; hydrolase activity; organelle; cilium organization; anatomical structure development; protein maturation
OG_05720,0.28669890126676,FUN_025626-T1,Peve_00023243,Pocillopora_meandrina_HIv1___RNAseq.g23126.t2a,three_way,80.867,FUN_025626-T1,Q9H0R3,TM222_HUMAN,,Transmembrane protein 222,Homo sapiens (Human),70.8,161.0,3.9000000000000004e-64,245.7,sp|Q9H0R3|TM222_HUMAN Transmembrane protein 222 OS=Homo sapiens OX=9606 GN=TMEM222 PE=1 SV=2,GO:0016020; GO:0030425,,dendrite [GO:0030425]; membrane [GO:0016020],,,
OG_05750,0.3929426431188783,FUN_025682-T1,Peve_00000456,Pocillopora_meandrina_HIv1___TS.g2103.t1,three_way,67.785,FUN_025682-T1,Q3UQ28,PXDN_MOUSE,,Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Mus musculus (Mouse),38.9,742.0,5.6000000000000005e-126,454.1,sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005198; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003,catalytic activity; structural molecule activity; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly
OG_05937,0.4138881540129175,FUN_026167-T1,Peve_00008134,Pocillopora_meandrina_HIv1___RNAseq.g3196.t1,three_way,63.132333333333335,,,,,,,,,,,,,,,,,
OG_05955,0.4442226441093188,FUN_026298-T1,Peve_00030620,Pocillopora_meandrina_HIv1___RNAseq.g3053.t1,three_way,82.72766666666666,FUN_026298-T1,Q13617,,,,,50.9,748.0,3.7e-225,782.7,sp|Q13617|CUL2_HUMAN Cullin-2 OS=Homo sapiens OX=9606 GN=CUL2 PE=1 SV=2,,,,,,
OG_06314,0.3901274199669416,FUN_028554-T1,Peve_00002501,Pocillopora_meandrina_HIv1___RNAseq.g20706.t2,three_way,70.67833333333333,FUN_028554-T1,A8MWY0,ELAP2_HUMAN,,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L),Homo sapiens (Human),35.5,1029.0,1.2e-176,622.1,sp|A8MWY0|ELAP2_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Homo sapiens OX=9606 GN=ELAPOR2 PE=1 SV=2,GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700,negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684],membrane [GO:0016020]; plasma membrane [GO:0005886],BMP receptor binding [GO:0070700],GO:0005886,plasma membrane
OG_06393,0.3848895876843166,FUN_029041-T1,Peve_00026017,Pocillopora_meandrina_HIv1___RNAseq.g20768.t1,three_way,78.406,,,,,,,,,,,,,,,,,
OG_06523,0.3608325385124061,FUN_029340-T1,Peve_00023362,Pocillopora_meandrina_HIv1___RNAseq.g17300.t2,three_way,70.36116666666666,FUN_029340-T1,Q99KY4,GAK_MOUSE,,Cyclin-G-associated kinase (EC 2.7.11.1) (DnaJ homolog subfamily C member 26),Mus musculus (Mouse),37.7,1476.0,1e-239,832.0,sp|Q99KY4|GAK_MOUSE Cyclin-G-associated kinase OS=Mus musculus OX=10090 GN=Gak PE=1 SV=2,GO:0002064; GO:0004674; GO:0005524; GO:0005794; GO:0005925; GO:0007029; GO:0007030; GO:0009913; GO:0010977; GO:0030136; GO:0030216; GO:0031982; GO:0035622; GO:0046907; GO:0048471; GO:0048853; GO:0048863; GO:0060563; GO:0061351; GO:0061436; GO:0072318; GO:0072583; GO:0106310; GO:1905443; GO:2000179,clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; epidermal cell differentiation [GO:0009913]; epithelial cell development [GO:0002064]; establishment of skin barrier [GO:0061436]; forebrain morphogenesis [GO:0048853]; Golgi organization [GO:0007030]; intracellular transport [GO:0046907]; intrahepatic bile duct development [GO:0035622]; keratinocyte differentiation [GO:0030216]; negative regulation of neuron projection development [GO:0010977]; neural precursor cell proliferation [GO:0061351]; neuroepithelial cell differentiation [GO:0060563]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of clathrin coat assembly [GO:1905443]; stem cell differentiation [GO:0048863],clathrin-coated vesicle [GO:0030136]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005794; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06952,0.1996792778599219,FUN_032065-T1,Peve_00024742,Pocillopora_meandrina_HIv1___RNAseq.g6040.t1,three_way,67.569,FUN_032065-T1,Q63HM2,,,,,39.0,1229.0,1.2e-228,795.0,sp|Q63HM2|PCX4_HUMAN Pecanex-like protein 4 OS=Homo sapiens OX=9606 GN=PCNX4 PE=1 SV=4,,,,,,
OG_07703,0.4943658035752764,FUN_034837-T1,Peve_00010449,Pocillopora_meandrina_HIv1___RNAseq.g27187.t1,three_way,85.81433333333334,FUN_034837-T1,Q6IWL4,TRAF6_DANRE,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Danio rerio (Zebrafish) (Brachydanio rerio),29.9,157.0,1.4e-08,62.0,sp|Q6IWL4|TRAF6_DANRE TNF receptor-associated factor 6 OS=Danio rerio OX=7955 GN=traf6 PE=1 SV=2,GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0008270; GO:0009615; GO:0009617; GO:0009898; GO:0031663; GO:0035591; GO:0038061; GO:0042981; GO:0043122; GO:0045087; GO:0045893; GO:0061630; GO:0070534; GO:0098978,innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of DNA-templated transcription [GO:0045893]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; response to bacterium [GO:0009617]; response to virus [GO:0009615],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07714,0.6378604798197304,FUN_034867-T1,Peve_00005778,Pocillopora_meandrina_HIv1___RNAseq.g27146.t1,three_way,75.34383333333334,FUN_034867-T1,Q28193,FURIN_BOVIN,,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin),Bos taurus (Bovine),49.8,616.0,5.7e-165,582.8,sp|Q28193|FURIN_BOVIN Furin OS=Bos taurus OX=9913 GN=FURIN PE=1 SV=1,GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0008201; GO:0010008; GO:0016486; GO:0046872; GO:0140447; GO:1904399,cytokine precursor processing [GO:0140447]; peptide hormone processing [GO:0016486],endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_07830,0.0468968812621269,FUN_035135-T1,Peve_00030331,Pocillopora_meandrina_HIv1___RNAseq.g27638.t1a,three_way,53.556,,,,,,,,,,,,,,,,,
OG_07892,0.3575573889510946,FUN_035271-T1,Peve_00011446,Pocillopora_meandrina_HIv1___RNAseq.g27865.t1,three_way,85.66933333333333,FUN_035271-T1,P57709,AT2C1_BOVIN,,Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1) (SPCA1),Bos taurus (Bovine),63.0,698.0,9e-245,847.8,sp|P57709|AT2C1_BOVIN Calcium-transporting ATPase type 2C member 1 OS=Bos taurus OX=9913 GN=ATP2C1 PE=2 SV=1,GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0016339; GO:0016887; GO:0030026; GO:0030036; GO:0030145; GO:0032468; GO:0032472; GO:0032580; GO:0033106; GO:0042998; GO:0043123; GO:0070588; GO:0098629; GO:0140613,actin cytoskeleton organization [GO:0030036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; intracellular calcium ion homeostasis [GO:0006874]; intracellular manganese ion homeostasis [GO:0030026]; manganese ion transport [GO:0006828]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; trans-Golgi network membrane organization [GO:0098629],cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; P-type calcium transporter activity [GO:0005388]; P-type manganese transporter activity [GO:0140613],GO:0003824; GO:0005215; GO:0005783; GO:0005794; GO:0005886; GO:0007010; GO:0007155; GO:0016787; GO:0043226; GO:0048856; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; endoplasmic reticulum; Golgi apparatus; plasma membrane; cytoskeleton organization; cell adhesion; hydrolase activity; organelle; anatomical structure development; transmembrane transport; membrane organization; ATP-dependent activity
OG_08184,0.1757089036294288,FUN_036021-T2,Peve_00001106,Pocillopora_meandrina_HIv1___RNAseq.g12317.t1,three_way,59.592,FUN_036021-T2,Q9HCD5,NCOA5_HUMAN,,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),Homo sapiens (Human),35.6,261.0,6.599999999999997e-29,131.0,sp|Q9HCD5|NCOA5_HUMAN Nuclear receptor coactivator 5 OS=Homo sapiens OX=9606 GN=NCOA5 PE=1 SV=2,GO:0000122; GO:0003682; GO:0003714; GO:0003723; GO:0005615; GO:0005654; GO:0008286; GO:0009966; GO:0015629; GO:0042593; GO:0046627,glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966],actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654],chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714],GO:0003723; GO:0005615; GO:0005654; GO:0005856; GO:0006355; GO:0043226; GO:0060090; GO:0140110,RNA binding; extracellular space; nucleoplasm; cytoskeleton; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_08415,0.3692708035633946,FUN_037071-T1,Peve_00004736,Pocillopora_meandrina_HIv1___RNAseq.g26783.t1,three_way,86.73233333333333,FUN_037071-T1,Q99973,TEP1_HUMAN,,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),Homo sapiens (Human),26.9,577.0,1.6999999999999998e-43,179.9,sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2,GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904,telomere maintenance via recombination [GO:0000722],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0006310; GO:0016740; GO:0032200; GO:0140097,"RNA binding; catalytic activity; DNA recombination; transferase activity; telomere organization; catalytic activity, acting on DNA"
OG_08856,0.626114646922958,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_08929,0.5653289581698371,FUN_038387-T1,Peve_00000060,Pocillopora_meandrina_HIv1___RNAseq.g28287.t1,three_way,63.87316666666666,FUN_038387-T1,P55202,,,,,36.6,940.0,3e-137,491.1,sp|P55202|ANPRB_ANGJA Atrial natriuretic peptide receptor 2 OS=Anguilla japonica OX=7937 GN=npr2 PE=2 SV=1,,,,,,
OG_09147,0.3208646799178844,FUN_039800-T1,Peve_00032689,Pocillopora_meandrina_HIv1___RNAseq.g7475.t1,three_way,61.298,FUN_039800-T1,Q9BQ24,ZFY21_HUMAN,,Zinc finger FYVE domain-containing protein 21 (ZF21),Homo sapiens (Human),39.2,102.0,2e-11,73.9,sp|Q9BQ24|ZFY21_HUMAN Zinc finger FYVE domain-containing protein 21 OS=Homo sapiens OX=9606 GN=ZFYVE21 PE=1 SV=1,GO:0005768; GO:0005925; GO:0008270,,endosome [GO:0005768]; focal adhesion [GO:0005925],zinc ion binding [GO:0008270],GO:0005768; GO:0031410; GO:0043226,endosome; cytoplasmic vesicle; organelle
OG_09161,0.2284120213689043,FUN_039820-T1,Peve_00009577,Pocillopora_meandrina_HIv1___RNAseq.g7314.t2,three_way,67.855,FUN_039820-T1,Q3U0J8,,,,,31.8,406.0,2.6e-50,202.6,sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2,,,,,,
OG_09229,0.3003432908924354,FUN_039966-T1,Peve_00039035,Pocillopora_meandrina_HIv1___RNAseq.g7517.t1a,three_way,70.402,,,,,,,,,,,,,,,,,
OG_09346,0.2306935872576358,FUN_040329-T1,Peve_00014960,Pocillopora_meandrina_HIv1___TS.g20804.t1,three_way,59.10066666666667,FUN_040329-T1,Q96JI7,SPTCS_HUMAN,,Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein),Homo sapiens (Human),27.8,1418.0,1.1e-133,480.3,sp|Q96JI7|SPTCS_HUMAN Spatacsin OS=Homo sapiens OX=9606 GN=SPG11 PE=1 SV=3,GO:0005730; GO:0005737; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007409; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030163; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0047496; GO:0048489; GO:0048675; GO:0048741; GO:0051668; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256,autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; localization within membrane [GO:0051668]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; walking behavior [GO:0090659],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202],protein kinase binding [GO:0019901],GO:0005730; GO:0005783; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0007018; GO:0007040; GO:0012501; GO:0023052; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0061024,nucleolus; endoplasmic reticulum; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; microtubule-based movement; lysosome organization; programmed cell death; signaling; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; membrane organization
OG_09394,0.1987546695200124,FUN_040692-T1,Peve_00042946,Pocillopora_meandrina_HIv1___RNAseq.g6443.t2,three_way,69.873,FUN_040692-T1,Q9QZM0,,,,,54.4,630.0,4.9000000000000004e-60,233.8,sp|Q9QZM0|UBQL2_MOUSE Ubiquilin-2 OS=Mus musculus OX=10090 GN=Ubqln2 PE=1 SV=2,,,,,,
OG_09486,0.3693774739865105,FUN_041519-T1,Peve_00024151,Pocillopora_meandrina_HIv1___RNAseq.g15592.t1,three_way,58.06766666666667,FUN_041519-T1,P27393,,,,,62.9,224.0,9e-84,314.3,sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1,,,,,,
OG_09701,0.2370899112525629,FUN_041932-T1,Peve_00023598,Pocillopora_meandrina_HIv1___RNAseq.g15699.t1,three_way,75.34166666666667,FUN_041932-T1,P53356,,,,,49.0,796.0,1e-215,751.5,sp|P53356|HTK16_HYDVU Tyrosine-protein kinase HTK16 OS=Hydra vulgaris OX=6087 GN=HTK16 PE=2 SV=1,,,,,,
OG_09811,0.4636837786496957,FUN_042633-T1,Peve_00030033,Pocillopora_meandrina_HIv1___RNAseq.19516_t,three_way,82.042,FUN_042633-T1,P08651,NFIC_HUMAN,,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),Homo sapiens (Human),48.2,390.0,3.2e-79,297.7,sp|P08651|NFIC_HUMAN Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0006366; GO:0042475; GO:0045944; GO:1990837,DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA replication; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_09881,0.4141805359918966,FUN_042949-T1,Peve_00019972,Pocillopora_meandrina_HIv1___TS.g886.t1,three_way,68.23983333333334,FUN_042949-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),34.1,560.0,6.8e-78,293.1,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09943,0.3327172039038256,FUN_043110-T1,Peve_00019983,Pocillopora_meandrina_HIv1___TS.g2567.t1,three_way,57.29733333333333,FUN_043110-T1,O73853,,,,,34.5,496.0,2.1e-86,321.2,"sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1",,,,,,
OG_10015,0.1557521007514919,FUN_043252-T1,Peve_00029557,Pocillopora_meandrina_HIv1___RNAseq.g8856.t1,three_way,77.27233333333334,FUN_043252-T1,F1QF89,POMT1_DANRE,,Protein O-mannosyl-transferase 1 (EC 2.4.1.109),Danio rerio (Zebrafish) (Brachydanio rerio),47.0,719.0,3.8000000000000004e-180,633.3,sp|F1QF89|POMT1_DANRE Protein O-mannosyl-transferase 1 OS=Danio rerio OX=7955 GN=pomt1 PE=1 SV=1,GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0042478; GO:0048742,protein O-linked mannosylation [GO:0035269]; regulation of eye photoreceptor cell development [GO:0042478]; regulation of skeletal muscle fiber development [GO:0048742],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169],GO:0003824; GO:0005783; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_10016,0.303020368863107,FUN_043253-T1,Peve_00029558,Pocillopora_meandrina_HIv1___TS.g20579.t1,three_way,86.185,FUN_043253-T1,Q9Z321,,,,,69.0,854.0,0.0,1221.5,sp|Q9Z321|TOP3B_MOUSE DNA topoisomerase 3-beta-1 OS=Mus musculus OX=10090 GN=Top3b PE=1 SV=1,,,,,,
OG_10078,0.2716138285815725,FUN_043387-T1,Peve_00024251,Pocillopora_meandrina_HIv1___RNAseq.g8999.t1,three_way,69.81466666666667,FUN_043387-T1,P02468,LAMC1_MOUSE,,Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma),Mus musculus (Mouse),41.9,1369.0,3.9000000000000004e-227,790.4,sp|P02468|LAMC1_MOUSE Laminin subunit gamma-1 OS=Mus musculus OX=10090 GN=Lamc1 PE=1 SV=2,GO:0005201; GO:0005576; GO:0005604; GO:0006325; GO:0007155; GO:0010467; GO:0016477; GO:0022617; GO:0031069; GO:0031175; GO:0031581; GO:0031594; GO:0035315; GO:0043083; GO:0043208; GO:0043259; GO:0045785; GO:0048729; GO:0051149; GO:0062023; GO:0065003; GO:0071335; GO:0098637; GO:0110011; GO:2001046,cell adhesion [GO:0007155]; cell migration [GO:0016477]; chromatin organization [GO:0006325]; extracellular matrix disassembly [GO:0022617]; gene expression [GO:0010467]; hair cell differentiation [GO:0035315]; hair follicle cell proliferation [GO:0071335]; hair follicle morphogenesis [GO:0031069]; hemidesmosome assembly [GO:0031581]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; tissue morphogenesis [GO:0048729],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin-10 complex [GO:0043259]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208],GO:0005198; GO:0005576; GO:0006325; GO:0007155; GO:0008289; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0034330; GO:0048870; GO:0065003,structural molecule activity; extracellular region; chromatin organization; cell adhesion; lipid binding; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; cell junction organization; cell motility; protein-containing complex assembly
